Innovation in practice: using genomic testing in routine care to boost population health – Becker’s Hospital Review

Genomic testing has been used for years on a case-by-case basis in clinical care, but is now increasingly seen as an important contributor to advancing population health.

During a September Becker's Hospital Review webinar sponsored by Helix a population genomics and viral surveillance company Feby Abraham, PhD, chief strategy officer of Houston-based Memorial Hermann Health System, and James Lu, MD, PhD, co-founder and CEO of Helix, discussed the role of genomics programs in supporting health systems' population and precision health objectives.

Three key takeaways were:

The strategic goals of the program, which will embed the Helix end-to-end platform, are to:

"We are going to innovate care delivery to inspire patients to [engage in] more proactive upfront interventions," Dr. Abraham said. He emphasized that higher patient engagement would be accomplished by intensifying patient education efforts as part of the genomic screening program. That, in turn, will improve patient retention, which is a key benefit for providers delivering care both under a fee-for-service and a value-based model.

As organizations embrace using genomic screening and data more broadly, integrated solutions that power large-scale clinical and research programs such as Memorial Hermann's will be central to implementing enterprise-wide genomics initiatives.

To view the full webinar,click here.

To register for upcoming webinars, click here.

Originally posted here:
Innovation in practice: using genomic testing in routine care to boost population health - Becker's Hospital Review